Antibacterial Compound from Aspergillus elegans SweF9 an Endophytic Fungus from Macroalgae Euchema sp. by Mulyani, Hani et al.
VOL 30 (3) 2019: 217–224 | RESEARCH ARTICLE 
217 
 Indonesian Journal of Pharmacy 
Indonesian  J Pharm 30(3),  2019, 217-224 | DOI: 10.14499/indonesianjpharm30iss3pp217  indonesianjpharm.farmasi.ugm.ac.id 
Copyright © 2019 THE AUTHOR(S). This article is distributed under a Creative Commons Attribution-ShareAlike 4.0 International 
(CC BY-SA 4.0) 
 
Antibacterial Compound from Aspergillus elegans SweF9 an Endophytic 
Fungus from Macroalgae Euchema sp. 
 
Hani Mulyani1,2, Rizna Triana Dewi2*, Chaidir1 
 
1.  Pharmacy  Faculty, Pancasila  University, Jl.  Raya  Lenteng  Agung Timur  No.56-80, Srengseng Sawah,  
Jagakarsa, Jakarta. 
2.  Research Center for Chemistry-Indonesian Institute of Sciences, Kawasan PUSPITEK, Serpong, 
Tangerang Selatan, Banten 15314. 
 
Info Article ABSTRACT 
Submitted: 25-02-2019 
Revised: 11-06-2019  
Accepted: 19-09-2019 
 
*Corresponding author 
Rizna Triana Dewi 
 
Email: 
riznatd@gmail.com 
 
 
The antibiotic resistance of phatogenic bacteria has become a serious health 
concern and encouragement to search for novel and efficient antimicrobial 
metabolites. On the other hand, endophytic fungi have great potential as a 
natural source for antimicrobial agents. The objective of this study was to 
isolate antibacterial compound from endophytic fungi A.elegans SweF9. The 
fungus was stationarily cultured at 30°C for 12 days in potato malt peptone 
(PMP) medium, then the filtrate was extracted with ethyl acetate. The 
antibacterial activities of the extract were evaluated by agar diffusion method 
against Gram-poitive (Bacillus subtilis and  Staphylococcus aureus) and Gram-
negative (Escherichia coli) bacterial strains. The broth extract at a 
concentration of 1% was able to inhibit the growth of E. coli, S. aureus and B. 
subtilis with an index of antibacterial activity 84.6%, 91.6%, and 90% 
compared to streptomycin sulfate at the same concentration. The active 
compound (1) was purified to yield amorphous white and identified using 
FTIR, NMR, and EI-MS analyses, revealed identified as (+) - epi-Epoformin. 
The compound showed an antibacterial activity index of against E. coli, S. 
aureus and B. subtilis  bacterial were 48%, 45%, and 47%, respectively, at 
concentration 1%.   
Keywords: Aspergillus elegans SweF9, antibacteria, (+)-epi- Epoformin. 
 
 
INTRODUCTION  
Resistance to antimicrobial (AMR) agents is a 
relevant problem faced by health services and has 
become a serious concern around the world (Elisha 
et al., 2017; Santos et al., 2015). Natural products 
such as fungi from terrestrial, marine, and 
endophytic are considered an essential source for 
novel antibacterial compounds because of their 
abundant species diversity, rich in secondary 
metabolites and the improvements in their genetic 
breeding and is it relevant with natural products as 
an essential source for novel antibacterial 
compounds (Calvo et al., 2002). Endophytic fungi 
have proved to be a rich source of bioactive 
secondary metabolites, and recently several novel 
bioactive substances have been isolated from these 
microorganisms such as Epipolysulfanyl–
dioxopiperazines (derivated of leptosins), were 
extracted from the endophytic fungus 
Leptosphaeria sp. isolated from the brown alga 
Sargasssum tortile showed the cytotoxicity against 
P-388 leukemia, and A. wentii pt-1 of marine red 
alga Gymnogongrus flabelliformis gifted another 
set of new xanthone derivatives, yicathin A C, 
exhibiting inhibitory activity against E. coli, S. 
aureus, and C. lagenarium  (Sarasan et al., 2017). 
The antimicrobial activities of an increasing 
number of fungi living in unique environments 
have been investigated for the discovery of new 
antibacterial compounds, such as endophytic fungi 
from wild plants and marine fungi. In the last 
decade, many novel bioactive natural products 
from marine fungi have been discovering that 
possess cytotoxic, anticancer, antiviral, 
antibacterial or antifungal activities (Thomas et al., 
2010; Rateb et al., 2011). Although the active 
constituents may occur in lower concentrations, 
endophytic fungi may be the better sources of new 
and active antibacterial compounds than synthetic 
drugs to combat infectious diseases 
(Kalyanasundaram et al., 2015). It is due to their 
characteristic properties regarding temperature, 
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nutrients, competition, and salinity, they have 
developed specific or unique secondary 
metabolites which have different chemical 
structure compared with terrestrial fungi and 
synthetic compounds (Hasan et al., 2015). 
The resource of marine fungal species is 
abundant, and the antibacterial compounds from 
marine fungi have quickly increased since 2010, for 
example, the marine fungus F. nypae had isolated 
2,2,7-trimethyl-2H-chromen-5-ol an antimicrobial 
activity for E. coli, B. subtilis, S. aureus, C. albicans, 
and S. pombe (Zainuddin et al., 2010). Endophytic 
from macroalgae  offer a wide range of potential 
therapeutic compounds as antibacterial, antifungal, 
antiviral, antioxidant, antitoxic, and anti-
inflammatory (Fujii et al., 2011). Endophytic A. 
wentii pt-1 of marine red alga Gymnogongrus 
flabelliformis gifted another set of new xanthone 
derivatives, yicathin A-C, exhibiting inhibitory 
activity against E. coli, S. aureus, and C. lagenarium 
(San et al., 2013). Felicio et al 2015, has isolated 
forty-five endophytic microorganism strains were 
isolated from Brazilian marine seaweed B. tenella 
(J.V.Lamouroux) J.Agardh and resulted active 
compound cytochalasin D a known antitumor and 
antibiotic compound from Xylaria sp. strain. 
Chemical investigation of various algal endophytes 
yielded a handful of metabolites inhibiting S. aureus 
as well as E. coli; namely, phenalenone derivatives 
and scleroderolide isolated from marine-derived 
fungus Coniothyrium cereal (Elsebai et al. 2011); 
dicerandrol C from the endophytic fungus 
Phomopsis longicolla isolated from the tropical red 
seaweed Bostrychiara dicans (Erbert et al. 2012); 
brevianamide M, 6,8-di-Omethylaverufin, and 6-O-
methylaverufin secondary metabolites from an 
algicolous A. versicolor strain (Miao, 2012). 
Although the association of macroalgae and 
fungi has been described regarding 
pharmacological issue, there is a lack of studies 
about Indonesian marine seaweed endophytic 
fungi. Srikandace and Andayani (2015), have 
reported sicx endophytic fungi from marine 
Euchema sp, namely SF1 (coral reef), SF3 (sponge), 
SwF5 (sea worm), SweF9 (seaweed), SweF10 
(seaweed), SweF11 showed antibacterial activity. 
Furthermore, extract of SweF9 (A. elegans) showed 
potential antibacterial activity with inhibition 
zones of 20-25mm at concentrations of 
0.313mg/mL and 2.50mg/mL, compared to  other 
ethyl acetate extract of isolated endophytic fungi. 
Therefore, the objective of this research was to 
isolate the antibacterial compound from 
endophytic fungi A. elegans SweF9. Bioautography-
TLC and agar diffusion method were conduct to run 
antibacterial activity against gram-negative and 
gram-positive pathogen bacterias. 
  
MATERIALS AND METHODS 
Materials 
The fungal A. elegans SweF9 culture 
collection of the Research Center for chemistry – 
LIPI and test microorganisms used were S. aureus 
(InaCC-B4), B. subtilis (InaCC-B334), and E. coli 
(InaCC-B5) bacteria collected of Indonesian Culture 
Collection of the Research enter for Biology – LIPI. 
was obtained from the Indonesian.  Culture media 
PDA, PDB, malt extract, peptone, Czapek-Dox broth 
were purchased from Difco. Streptomycin sulphate 
from Sigma. Silica gel 70-230 mesh and TLC plate 
were obtained from eMerck. All solvents used were 
analytical grade and distilled before use. 
UV Spectra were recorded in MeOH on an 
Agilent Techn. Carry 60 spectrophotometer. The 1H 
NMR spectra were recorded in CDCl3 on Agilent 
500MHz with DD2 console system, while 13C NMR 
at 125MHz. The chemical shift values (δ) are given 
in parts per million (ppm) and coupling constant 
(+) (J) in Hz. ESI-MS analysis was conducted by 
LCMS/MS Xevo G2-XS QTOF (Waters). Column 
chromatography was performed on silica gel (E. 
Merck, 70–230 mesh). TLC separation were 
performed on precoated plates (Silica gel 60, 
PF254, 0.2mm, E. Merck) and spots were detected 
under UV light.  
 
Optimization of Culture Medium 
The strains were prepared on PDA plates 
and incubated at 30ºC for seven days in the dark.  A. 
elegant SweF9 was cultivation in three different 
media: potato dextrose broth (PDB), potato malt 
peptone (PMP) and Czapek-Dox broth (CDB) 
incubated for ten days in room temperature at 
static condition. The culture media and mycelium 
were separated by filtration. The mycelium (B) and 
filtrate (F) was extracted with EtOAc. Each of 
organic extract was dried over anhydrous Na2SO4, 
evaporated under reduced pressure to afford a 
brown oily gummy residue. All extracts were tested 
for their antibacterial activity.  
 
Determination of the incubation period 
The strain A. elegan SweF9 was inoculated 
into PMP medium, incubated up to 20 days in 
stationary condition at room temperature. Their 
growth and secondary metabolite production were 
determined every two days by comparing mycelial 
weight and antibacterial activity. 
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Extraction and Isolation 
 Secondary metabolites extraction was 
carried out by culturing A. elegans SweF9 in PMP 
(10 L) incubated for 12 days at room temperature 
at static condition. The culture were filtered to 
separate (filtrate) and mycelia (residual cake). The 
filtrate (F) was ecxtracted with EtOAc (4x5L) to 
give a brown gum (6.35g). The F extract (4.5g) was 
subjected to column chromatography (CC) on silica 
gel (70-230 mesh) using a stepwise gradient n-
hexane: EtOAc, to EtOAc: MeOH to obtain twelve 
fractions (F1-F12) based on TLC profile analysis. 
The fraction F2 showed highest inhibition zone             
on bacterial tests and Furthermore, TLC analysis of 
F2, showed major spot with 2 minor other spots. 
For isolation of antibacterial compounds, semi 
preparative TLC was used. To obtain bigger 
amounts of fractions, 150µL of F2 in a 15cm band 
was applied on TLC plate and developed to an 8cm 
distance with phase mobil of n-hexane: EtOAc (2:1). 
Separated fractions was scraped off together with 
silica gel, then was extracted with MeOH and 
concentrated. Recrystallization of the extract from 
methanol and n-hexane to yield F2.1 (20mg) as an 
active compound (1).  
 
Antimicrobial activities assay 
Agar disk-diffusion method 
Extracts, fractions and isolated compound 
were tested by disc diffusion method 
(Kalyanasundaram et al., 2015).  The sterile 
nutrient agar (NA) media plates were prepared and 
inoculated with the test organism. Ten microliters 
of samples (1%) was added on to a sterile 6 mm 
paper disc using a micropipette and allowed to dry. 
Discs containing compounds were placed on the 
surface of the medium. The experiment was carried 
out in triplicates. Streptomycin sulphate (1%) was 
used as positive control and 10µL of DMSO was 
used as negative controls. The plates were 
incubated at ±35 for 12-24h. The diameter of the 
inhibition zone (mm) around the disc was 
measured by using the scale. The value of activity 
was adjusted to Activity Index= (Zone of inhibition 
of extract/Zone of inhibition of antibiotic) x 100%. 
 
Thin layer chromatography (TLC)-
bioautography 
The procedure autobiographic method is 
similar with agar difusion method.  TLC plate 
(Merck Silica Gel 60 F254) was loaded with 10µL of 
fraction F2. The solvent system used was n-hexane: 
EtOAc (2:1). The chromatogram was kept for 
evaporation of the solvent then placed on the 
bacterial inoculated agar surface for a few minutes 
to allow diffusion. Next, the plate is removed and 
the agar plate was incubated. The zone of inhibition 
growth appears in the places, where the 
antimicrobial compounds were in contact with the 
agar layer (Choma et al., 2015). The antimicrobial 
activity was observed by inhibition zone and the Rf 
value was defined.  
 
RESULTS AND DISCUSSION 
Optimization of culture condition 
To examine the effect of culture medium               
on antibacterial activity of secondary metabolite, 
the strain A. elegans SweF9 was cultured in                 
three different mediums, PDB, PMP, and CzB            
under static condition for ten days at room 
temperature. all extracts obtained were tested              
for antibacterial activity (Table I). Based on the 
result, the antibacterial activity of extracts of               
PDB and PMP does not differ significantly. 
However, extract (F) PMP shows stronger 
antibacterial activity, where the inhibition zone               
at the lowest concentration (1%) was wider             
than    inhibition    zones   of    the    other    extracts.  
Table I. Antibacterial activity from three different culture broths of A. elegan SweF9                
 
No Extract*  
Inhibition zone (mm) Activity index (%) 
E. coli S. aureu B. subtilis E. coli     S. aureus B. subtilis 
1 PDB (B) 11 14 16 48 70 59 
2 PDB (F) 15 14 19 65 70 70 
3 PMP (B) 14 15 16 61 75 59 
4 PMP (F) 17 16 21 74 80 78 
5 CDB (B) 7 - 7 30 - 26 
6. CDB (F) 8 - 8 35 - 30 
7. Streptomycin Sulfate 23 20 27    
   
Annotation: B = Biomasa; F = filtrate. *Sample concentration: 1% 
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The result showed that antibacterial compounds 
were efficiently produced when the fungus A. 
elegans SweF9 was fermented in PMP medium. The 
activity index of PMP filtrate extract (1%) on E. coli, 
S aureus, and B. subtilis to streptomycin sulfate as 
standard were 74, 80, and 78%, respectively. 
Therefore, the PMP culture media was chosen for 
scale up of antibacterial compound from A. elegans 
SweF9. Further studies to determinant the 
optimum incubation period of A. elegan SweF9, 
revealed that incubation period for 12 days was 
observed to be optimum for maximum inhibition 
against E. coli, S. aureus, and B. subtilis with 
inhibition zone 22, 22, and 2mm, respectively. The 
activity index for this extract was 84.6%, 91.6% 
and 90% (Figure 1). Based on that result,  A. elegan 
SweF9 could produced antibacterial agent after the 
fungus reached its stationary phase and decreased 
up to 12 days of incubation and remaining almost 
constant from 14 to 20 days’ incubation. Based on 
these results, for scale up production to isolation 
antibacterial agent, A. elegan SweF9 was cultured in 
PMP medium (10L) at the stationary condition for 
12 days.  
 
Isolation and characterization of antibacterial 
compound 
Approximately ~ 6.5g filtrate EtOAc extract 
(F) was obtained from the culture broth (10L).              
The extract (F) was examined against pathogen 
bacterial by TLC-bioautographic test. The 
bioautographic revealed clear zones of bacterial 
growth inhibition for E. coli, S. aureus, and B. subtilis 
were 30, 27, 29mm (Figure 2). Bioautographic 
belongs to microbiological screening methods 
commonly used for the detection of anti-             
microbial activity from several organic extracts,                  
mainly    plant    extract    (Jesionek    et   al.,   2015).  
 
 
Figure 1.  The index of antibacterial activity against the influence of fermentation time 
 
 
 
Figure 2. TLC-bioautographic of F extract of A. elegan SweF9 against S. aureus, B. subtilis, and E. coli. (a) 
before incubation; (b) after incubation  
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In this study, we used agar diffusion-TLC 
bioautographic also known as an agar contact 
method. It involved the transfer of the 
antimicrobial agent by diffusion from TLC to an 
agar plate previously inoculated with 
microorganism test (Choma, et al., 2015). It is one 
of the simplest and cheapest methods for detecting 
antimicrobial compounds in extracts or fraction 
because the method is easy to run, reproducible, 
highly sensitive and requires less equipment 
(Jesionek et al., 2015). 
Separation of the extract F (±5.5g) was 
conducted by vacuum column chromatography 
with gradual polarity increase to obtain 12 
fractions (F1-F12) based on TLC profile. Each 
fraction obtained was tested for its antibacterial 
activity. Fraction F-2, F-3, and F-4 have wider 
inhibition zona than other fractions against three 
bacteria tests (Table II). Based on that result, F-2 
and F-3 fraction were further purified, whereas F4 
was not purified due to the limited of sample 
(<100mg). The F3 fraction was purified by 
chromatography column, but no pure active 
compound was isolated. Preparative-TLC and 
recrystallization of F2 with hexane and methanol to 
yield powder white (20mg) referred to as 
compound 1. In agar diffusion assays (Table III), 
compound 1 was active against E. coli, S. aureus, and 
B. subtilis with an activity index of   48, 45 and 47%, 
respectively.   
Spectroscopic analysis was conducted to 
elucidate the structure of the active compound. 
Compound 1 was obtained as powder white and 
showed FTIR absorption bands at 3336 and 
1678cm-1 which indicated the presence of hydroxyl 
(-OH) and carbonyl (C=O) groups, respectively. 
(Cala et al., 2018). The molecular formula was 
deduced to be C7H8O3 with two unsaturation’s from 
EI-MS (m/z 141).   
In order to elucidate the compound’s 
structure, NMR measurements were carried                     
out in CDCl3. Interpretation of 1H- and 13C-NMR 
spectra confirmed the presence of 6 carbon               
atoms and 6 proton signals, including methyl                 
and hydroxyl groups. 1H chemical shift at δH 6.45 
(brs, 1H, H-3) shows the proton shift bound                   
to double bonded carbon (HC=C), δH 4.65 (brs,                  
1H, H-4),  3.78 (m, 1H, H-5),  and 3.50 (m, 1H, H-6),   
Table II. Antibacterial activity of fraction from EtOAc extract of A. elegans SweF9 
 
Fraction* Yield (mg) 
Inhibition Zone (mm) Activity index (%) 
E. coli S. aureus B. subtilis E. coli S. aureus B. subtilis 
Extract F 5500 30 27 29   100 100 96.6 
F1 34.6 - - - - - - 
F2 115 22 20 22 73.3 76.9 73.3 
F3 1399.5 23 22 20 76.6 84.6 66.6 
F4 87.6 20 25 25 66.6 96.1 83.3 
F5 233.8 10 - 10 33.3 - 33.3 
F6 166.6 - - - - - - 
F7 637.7 - - - - - - 
F8 369.1 - - 7 - - 23.3 
F9 67.2 - - - - - - 
F10 300.4 - - - - - - 
F11 70.2 - - - - - - 
F12 1580.3 9 8 - 30 30.7 - 
Streptomycin Sulfate  30 26 30    
 
*Sample concentration: 1% 
 
Table III.  Antibacterial activity of compound 1  
 
Sample 
Inhibition Zone(mm) Activity index (%) 
E. coli S. aureus B. subtilis E. coli S. aureus B. subtilis 
Compound 1 10 8 8 48 45 47 
Streptomycin sulfate 21 18 17    
 
*Sample concentration: 1% 
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indicating the presence of 3 protons metin-oxy 
(CH-O), and δH 1.84 (s, 3H, H-7) is a typical 
chemical shift for methyl (-CH3). The presence of a 
hydroxyl (-OH) proton was inferred from the 
signals at δH 2, 29.  
The number of carbon atom was a 
measurement with 13C-NMR, spectrum revealed 
seven peaks in the range δC 19-194ppm. The shift 
at δC 194.4 ppm is the typical shift for ketone 
carbonyl (C=O), shift at δC 134.7ppm, and 
138.9ppm is the shift of carbon double bond (C =C), 
63.5ppm, 57, 8 ppm, 53.5ppm is metin C oxy which 
CH binds to O and 16.1 ppm is C methyl (-CH3). The 
complete structural elucidation of 1 as well as the 
unambiguous assignment of all 1H- and 13C-NMR 
signals was based on 2D NMR experiments (HMQC 
and HMBC) (Figure 3). An experiment with the 
HMQC spectrum shows protons at δH 6.45 (H-3) 
correlate with carbon at C 138.9. The proton at 4.65 
(H-4) correlates with carbon at δC 63.5. Proton δH 
3.78 (H-5) correlates with carbon at δC 57.8, proton 
δH 3.50 (H-6) correlates with δC 53.5, and the 
presumption of the presence of one methyl group is 
supported by proton correlation δH 1.84 with 
carbon at δC 16.1. The proton at δH 6.45 has a long-
distance correlation with three atoms at δc 194.4; 
57.8; and 16.1 ppm. The proton at 4.65 (H-4) 
correlates with carbon at C at 138c 138.9, proton 
3.78 (H-5) correlates with C-3 (δC 138.9). Proton 
δH 3.50 (H-6) correlates remotely with two carbon 
atoms at δC 194.4 (C-1) and δC 134.7 (C-2). While 
the proton 84H 1.84 (H-7) shift ppm correlates 
with three carbon atoms in the area δc194.4 (C-1), 
δC 134.7 (C-2), and δC 138.9 (C-3). The 1H- and 13C-
NMR of compound 1 (Table IV).  
According to the spectroscopic data and 
literature as comparisons (Cala et al., 2018; 
Nagasawa et al., 1978), compound 1 was 
determined as 5-hydroxy-3-methyl-7-oxabicyclo 
[4.1.0] hept-3-en-2-one, trivial name is epi-
epoformin compounds.  (+) - Epi-Epoformin was 
isolated firstly from unidentified fungus, which was 
separated from the diseased leaf of crapemyrtle 
(Lagerstroemia indica L.) and showed the marked 
inhibition against the germination of lettuce seeds, 
Lactuca sativa L. (Nagasawa et al, 1978).  Recently, 
this compound was also used as a fungicide to 
inhibit the growth of Puccinia pathogenic fungi and 
 
 
Figure 3.  HMQC and HMBC ccorrelation of compound 1 ((+)-epi-Epoformin) 
 
Table IV. NMR Data (400 MHz. Chloroform- CDCl3) of Epi-epoformin (Cala et al., 2018) 
 
Compound 1 Epi-epoformin 
No δ (J in Hz) δC mult HMBC (H to C) No δ (J in Hz) δC mult HMBC (H to C) 
1 - 194 - 1 - 193.5 - 
2 - 138.9 - 2 - 136.6 - 
3 6.45 (1H, m) 134.7 1,5,7 3 6.46 (1H, brs) 134.3 1,5,7 
4 4.65 (1H, br) 63.5 3 4 4.67 (1H, brs) 64.5 3 
5 3.78 (1H, m) 57.8 3 5 3.78 (1H, m) 55.0 3 
6 3.50 (1H, m) 53.5 1, 2 6 3.53 (1H, m) 52.9 1, 2 
7 1.84 (3H, s) 16.1 1,2,3 7 1.86 (3H, s) 16.05 1,2,3 
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Uromyces which are pathogenic in legumes (Barilii 
et al., 2016).  The biological activity of epiformin is 
better known as an antifungal or fungicide, while 
antibacterial activity has not been reported before. 
Furthermore, this compound has not been reported 
to be isolated from A. elegans isolated from marine 
biota.  
 
CONCLUSION 
In summary, endophytic fungi A. elegans 
SweF9 isolated from Euchema sp, possess 
antibacterial activity against tested bacteria, and 
revealed (+)-Epi-Epoformin as the active 
compound. Our results suggest that the fungal 
endophytes of A. elegans SweF9 could be an 
appropriate source of bioactive secondary 
metabolites.  
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